专利号:US-2014315720-A1 优先权日:2012-10-24 标 题 :Polysaccharide ester microspheres and methods and articles relating thereto 发明人:FALLON DENIS G; GARRETT THOMAS S; KIZER LAWTON E; ZAZZARA KAREN L; COMBS MICHAEL T; JOHNSON RICHARD K; DEHART GARY 权利人:CELANESE ACETATE LLC 摘要:A method for producing a polysaccharide ester microsphere may include forming a polysaccharide ester product from a polysaccharide synthesis, wherein the polysaccharide ester product comprises a polysaccharide ester and a solvent; diluting the polysaccharide ester product, thereby yielding a polysaccharide ester dope; and forming a plurality of polysaccharide ester microspheres from the polysaccharide ester dope. Suitable polysaccharides may include, but are not limited to, starch, cellulose, hemicellulose, algenates, chitosan, and any combination thereof. Esters thereof may be organic esters (e.g., acetate and the like), inorganic esters (e.g., sulfonates and the like), or combinations thereof. Further, the solids conent of the polysaccharide ester dope, in some instances, may be greater than about 16 wt %.
1: Loeppky RN, Shi J, Barnes CL, Geddam S. A diazonium ion cascade from the nitrosation of tolazoline, an imidazoline-containing drug. Chem Res Toxicol. 2008 Feb;21(2):295-307. doi: 10.1021/tx700317g. Epub 2008 Feb 2. Review.
合成参考文献
摘要:Folia Medica, 27(729), 1941 参考文献:10.1007/bf00171054 摘要:Molderings GJ, Schmidt K, Bönisch H, Göthert M. Inhibition of 5-HT3 receptor function by imidazolines in mouse neuroblastoma cells: potential involvement of sigma 2 binding sites. Naunyn Schmiedebergs Arch Pharmacol. 1996 Aug;354(3):245–52. doi: 10.1007/bf00171054. 参考文献:10.1007/bf00171069 摘要:Ishikawa H, Miller DD, Patil PN. Irreversible agonist and antagonist properties of isothiocyanatobenzyl imidazoline in albino rabbit iris muscles. Naunyn Schmiedebergs Arch Pharmacol. 1996 Aug;354(3):362–8. doi: 10.1007/bf00171069. 参考文献:10.1007/s001340051022 摘要:Beghetti M, Morris K, Cox P, Bohn D, Adatia I. Inhaled nitric oxide differentiates pulmonary vasospasm from vascular obstruction after surgery for congenital heart disease. Intensive Care Med. 1999 Oct;25(10):1126–30. doi: 10.1007/s001340051022.